A modified weighted log-rank test for confirmatory trials with a high proportion of treatment switching | PLOS ONE
![Mathematics | Free Full-Text | Weighted Log-Rank Test for Clinical Trials with Delayed Treatment Effect Based on a Novel Hazard Function Family Mathematics | Free Full-Text | Weighted Log-Rank Test for Clinical Trials with Delayed Treatment Effect Based on a Novel Hazard Function Family](https://pub.mdpi-res.com/mathematics/mathematics-10-02573/article_deploy/html/images/mathematics-10-02573-g001.png?1658739336)
Mathematics | Free Full-Text | Weighted Log-Rank Test for Clinical Trials with Delayed Treatment Effect Based on a Novel Hazard Function Family
![Mathematics | Free Full-Text | Weighted Log-Rank Test for Clinical Trials with Delayed Treatment Effect Based on a Novel Hazard Function Family Mathematics | Free Full-Text | Weighted Log-Rank Test for Clinical Trials with Delayed Treatment Effect Based on a Novel Hazard Function Family](https://www.mdpi.com/mathematics/mathematics-10-02573/article_deploy/html/images/mathematics-10-02573-g004.png)
Mathematics | Free Full-Text | Weighted Log-Rank Test for Clinical Trials with Delayed Treatment Effect Based on a Novel Hazard Function Family
![Group sequential monitoring based on the maximum of weighted log-rank statistics with the Fleming–Harrington class of weights in oncology clinical trials - Thomas J Prior, 2020 Group sequential monitoring based on the maximum of weighted log-rank statistics with the Fleming–Harrington class of weights in oncology clinical trials - Thomas J Prior, 2020](https://journals.sagepub.com/cms/10.1177/0962280220931560/asset/images/large/10.1177_0962280220931560-fig1.jpeg)
Group sequential monitoring based on the maximum of weighted log-rank statistics with the Fleming–Harrington class of weights in oncology clinical trials - Thomas J Prior, 2020
A modified weighted log-rank test for confirmatory trials with a high proportion of treatment switching | PLOS ONE
![Properties of the weighted log‐rank test in the design of confirmatory studies with delayed effects - Jiménez - 2019 - Pharmaceutical Statistics - Wiley Online Library Properties of the weighted log‐rank test in the design of confirmatory studies with delayed effects - Jiménez - 2019 - Pharmaceutical Statistics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b2f83564-6cec-4a99-9cb3-78cb118137fc/pst1923-fig-0006-m.jpg)
Properties of the weighted log‐rank test in the design of confirmatory studies with delayed effects - Jiménez - 2019 - Pharmaceutical Statistics - Wiley Online Library
![A weighted log‐rank test and associated effect estimator for cancer trials with delayed treatment effect - Yu - 2021 - Pharmaceutical Statistics - Wiley Online Library A weighted log‐rank test and associated effect estimator for cancer trials with delayed treatment effect - Yu - 2021 - Pharmaceutical Statistics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e26e777e-93d1-4be3-acaf-525e6101247e/pst2092-fig-0001-m.jpg)
A weighted log‐rank test and associated effect estimator for cancer trials with delayed treatment effect - Yu - 2021 - Pharmaceutical Statistics - Wiley Online Library
![CIMAvax<sup>®</sup>EGF vaccine therapy for non-small cell lung cancer: A weighted log-rank tests-based evaluation CIMAvax<sup>®</sup>EGF vaccine therapy for non-small cell lung cancer: A weighted log-rank tests-based evaluation](https://www.scirp.org/html/paperimages/34723_1.jpg)
CIMAvax<sup>®</sup>EGF vaccine therapy for non-small cell lung cancer: A weighted log-rank tests-based evaluation
![Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-28410-9/MediaObjects/41467_2022_28410_Fig1_HTML.png)
Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications
![Estimation of Information Fraction with Fleming- Harrington type weighted log-rank test in clinical trials with interim look Madan G Kundu, PhD AbbVie. - ppt download Estimation of Information Fraction with Fleming- Harrington type weighted log-rank test in clinical trials with interim look Madan G Kundu, PhD AbbVie. - ppt download](https://slideplayer.com/17759113/105/images/slide_1.jpg)
Estimation of Information Fraction with Fleming- Harrington type weighted log-rank test in clinical trials with interim look Madan G Kundu, PhD AbbVie. - ppt download
![Mathematics | Free Full-Text | Weighted Log-Rank Test for Clinical Trials with Delayed Treatment Effect Based on a Novel Hazard Function Family Mathematics | Free Full-Text | Weighted Log-Rank Test for Clinical Trials with Delayed Treatment Effect Based on a Novel Hazard Function Family](https://www.mdpi.com/mathematics/mathematics-10-02573/article_deploy/html/images/mathematics-10-02573-g006.png)
Mathematics | Free Full-Text | Weighted Log-Rank Test for Clinical Trials with Delayed Treatment Effect Based on a Novel Hazard Function Family
Weighted Log Rank Type Statistics for Comparing Survival Curves when There is a Time Lag in the Effectiveness of Treatment
![Properties of the weighted log‐rank test in the design of confirmatory studies with delayed effects - Jiménez - 2019 - Pharmaceutical Statistics - Wiley Online Library Properties of the weighted log‐rank test in the design of confirmatory studies with delayed effects - Jiménez - 2019 - Pharmaceutical Statistics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/7aabb514-f9f6-489e-920c-cfa4cd698d63/pst1923-fig-0001-m.jpg)